Operating Lease, Right-of-Use Asset in USD of BioCardia, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioCardia, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • BioCardia, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $599K, a 39.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BioCardia, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $599K -$394K -39.7% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $702K -$383K -35.3% 30 Jun 2025 10-Q/A 29 Oct 2025
Q1 2025 $801K -$373K -31.8% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $898K -$363K -28.8% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $993K -$353K -26.2% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $1.09M -$344K -24.1% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $1.17M -$335K -22.2% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $1.26M -$327K -20.6% 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $1.35M -$318K -19.1% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $1.43M -$310K -17.8% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $1.51M -$303K -16.7% 31 Mar 2023 10-Q 10 May 2023
Q4 2022 $1.59M -$295K -15.7% 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $1.66M +$1.52M +1017% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $1.74M +$1.45M +494% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $1.81M +$1.38M +319% 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $1.88M +$1.32M +232% 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $149K -$548K -78.6% 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $293K -$531K -64.4% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $432K -$515K -54.4% 31 Mar 2021 10-Q 13 May 2021
Q4 2020 $567K -$498K -46.8% 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 $697K -$483K -40.9% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $824K -$468K -36.2% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $947K -$453K -32.4% 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $1.07M -$440K -29.2% 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 $1.18M 30 Sep 2019 10-Q 19 Nov 2019
Q2 2019 $1.29M 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $1.4M 31 Mar 2019 10-Q 15 May 2019
Q4 2018 $1.51M 01 Jan 2019 10-Q 19 Nov 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.